MEIP
Price
$2.69
Change
+$0.09 (+3.46%)
Updated
Jul 10 closing price
Capitalization
18.32M
VXRT
Price
$0.35
Change
+$0.05 (+16.67%)
Updated
Jul 10 closing price
Capitalization
73.03M
27 days until earnings call
Interact to see
Advertisement

MEIP vs VXRT

Header iconMEIP vs VXRT Comparison
Open Charts MEIP vs VXRTBanner chart's image
MEI Pharma
Price$2.69
Change+$0.09 (+3.46%)
Volume$8.22K
Capitalization18.32M
Vaxart
Price$0.35
Change+$0.05 (+16.67%)
Volume$1.83M
Capitalization73.03M
MEIP vs VXRT Comparison Chart in %
Loading...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEIP vs. VXRT commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEIP is a Buy and VXRT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (MEIP: $2.69 vs. VXRT: $0.35)
Brand notoriety: MEIP and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEIP: 57% vs. VXRT: 39%
Market capitalization -- MEIP: $18.32M vs. VXRT: $73.03M
MEIP [@Biotechnology] is valued at $18.32M. VXRT’s [@Biotechnology] market capitalization is $73.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEIP’s FA Score shows that 0 FA rating(s) are green whileVXRT’s FA Score has 1 green FA rating(s).

  • MEIP’s FA Score: 0 green, 5 red.
  • VXRT’s FA Score: 1 green, 4 red.
According to our system of comparison, MEIP is a better buy in the long-term than VXRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEIP’s TA Score shows that 5 TA indicator(s) are bullish while VXRT’s TA Score has 5 bullish TA indicator(s).

  • MEIP’s TA Score: 5 bullish, 3 bearish.
  • VXRT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MEIP is a better buy in the short-term than VXRT.

Price Growth

MEIP (@Biotechnology) experienced а +0.37% price change this week, while VXRT (@Biotechnology) price change was -20.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

MEIP is expected to report earnings on May 13, 2025.

VXRT is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VXRT($73M) has a higher market cap than MEIP($18.3M). MEIP YTD gains are higher at: 9.350 vs. VXRT (-47.591). MEIP has higher annual earnings (EBITDA): -22.17M vs. VXRT (-45.73M). VXRT has more cash in the bank: 41.9M vs. MEIP (20.5M). MEIP has less debt than VXRT: MEIP (11.7M) vs VXRT (16.8M). VXRT has higher revenues than MEIP: VXRT (47.4M) vs MEIP (0).
MEIPVXRTMEIP / VXRT
Capitalization18.3M73M25%
EBITDA-22.17M-45.73M48%
Gain YTD9.350-47.591-20%
P/E Ratio1.09N/A-
Revenue047.4M-
Total Cash20.5M41.9M49%
Total Debt11.7M16.8M70%
FUNDAMENTALS RATINGS
MEIP vs VXRT: Fundamental Ratings
MEIP
VXRT
OUTLOOK RATING
1..100
1478
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
4192
P/E GROWTH RATING
1..100
43100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VXRT's Valuation (25) in the Biotechnology industry is in the same range as MEIP (55) in the Pharmaceuticals Other industry. This means that VXRT’s stock grew similarly to MEIP’s over the last 12 months.

VXRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MEIP (100) in the Pharmaceuticals Other industry. This means that VXRT’s stock grew similarly to MEIP’s over the last 12 months.

VXRT's SMR Rating (98) in the Biotechnology industry is in the same range as MEIP (98) in the Pharmaceuticals Other industry. This means that VXRT’s stock grew similarly to MEIP’s over the last 12 months.

MEIP's Price Growth Rating (41) in the Pharmaceuticals Other industry is somewhat better than the same rating for VXRT (92) in the Biotechnology industry. This means that MEIP’s stock grew somewhat faster than VXRT’s over the last 12 months.

MEIP's P/E Growth Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for VXRT (100) in the Biotechnology industry. This means that MEIP’s stock grew somewhat faster than VXRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MEIPVXRT
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Bullish Trend 29 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BDN4.300.15
+3.61%
Brandywine Realty Trust
CLGN1.410.02
+1.31%
CollPlant Biotechnologies Ltd
RMD258.072.09
+0.82%
ResMed
EHTH4.14-0.02
-0.48%
eHealth
PBH77.54-1.32
-1.67%
Prestige Consumer Healthcare

MEIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with GOSS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
+3.46%
GOSS - MEIP
45%
Loosely correlated
N/A
DNLI - MEIP
29%
Poorly correlated
+2.33%
AXON - MEIP
28%
Poorly correlated
-9.04%
NRIX - MEIP
27%
Poorly correlated
-3.87%
GLUE - MEIP
27%
Poorly correlated
-0.57%
More